BioNTech Announces First Quarter 2024 Financial Results and Corporate Update Read more about BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 Read more about BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer Read more about Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
Fourth Quarter and Full Year 2023 Earnings Presentation Read more about Fourth Quarter and Full Year 2023 Earnings Presentation
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Read more about BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer Read more about BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024 Read more about BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
BioNTech Announces Planned Retirement of Sean Marett Read more about BioNTech Announces Planned Retirement of Sean Marett
